*ST熊貓(600599.SH):終止非公開發行股票事宜
格隆匯 12 月 28日丨*ST熊貓(600599.SH)公佈,公司於2020年12月28日召開的第六屆董事會第二十四次會議和第六屆監事會第十六次會議審議通過了《關於終止非公開發行股票事宜的議案》。公司決定終止此次非公開發行股票相關事項。
鑑於公司2019年度被年審會計師事務所出具了帶保留意見的審計報吿,且審計報吿中涉及的保留事項一直未能消除,公司非公開發行股票事項一直未能如期推進。寰瓊科技經慎重考慮後,決定終止與公司的非公開發行事項,不再認購公司非公開發行的股份。經雙方協商,綜合考慮公司目前的實際情況,公司同意終止本次非公開發行股票相關事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.